Bicyclic cyanoheterocycles, process for their preparation...

Details Bicyclic cyanoheterocycles, process for their preparation... Bicyclic cyanoheterocycles, process for their preparation...

2006-03-07

2006-03-07

McKane, Joseph K. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S152000, C548S179000, C546S198000, C546S270100, C544S133000, C544S368000, C540S480000, C540S603000, C514S321000, C514S338000, C514S233200, C514S254020, C514S217100

Reexamination Certificate

active

07008957

ABSTRACT:
The invention relates to compounds of the formula Iin which the radicals have the stated meanings, their stereoisomeric forms and their physiologically tolerated salts and process for their preparation.The compounds are suitable for the treatment of metabohlic disorders such as type 2 diabetes.

REFERENCES:
patent: 6221633 (2001-04-01), Ertl et al.
patent: 6221897 (2001-04-01), Frick et al.
patent: 6245744 (2001-06-01), Frick et al.
patent: 6329403 (2001-12-01), Odaka et al.
patent: 6342512 (2002-01-01), Kirsch
patent: 6380357 (2002-04-01), Hermeling et al.
patent: 6624185 (2003-09-01), Glombik
patent: 6884812 (2005-04-01), Glombik
patent: 10142734 (2003-03-01), None
patent: WO 91/11457 (1991-08-01), None
patent: WO 97/26265 (1997-07-01), None
patent: WO 97/41097 (1997-11-01), None
patent: WO 99/03861 (1999-01-01), None
patent: WO 99/15525 (1999-04-01), None
patent: WO 99/31507 (1999-06-01), None
patent: WO 00/34332 (2000-06-01), None
patent: WO 03/34331 (2000-06-01), None
patent: WO 00/40569 (2000-07-01), None
patent: WO 00/63208 (2000-10-01), None
patent: WO 00/64876 (2000-11-01), None
patent: WO 00/64888 (2000-11-01), None
patent: WO 00/66585 (2000-11-01), None
patent: WO 00/71549 (2000-11-01), None
patent: WO 00/78312 (2000-12-01), None
patent: WO 01/04156 (2001-01-01), None
patent: WO 01/09111 (2001-02-01), None
patent: WO 01/83451 (2001-11-01), None
patent: WO 01/85695 (2001-11-01), None
patent: WO 01/91752 (2001-12-01), None
Baures, et al., “Design, Synthesis, and Dopamine Receptor-Modulating Activity of Diketopiperazine Peptidomimetics of L-Prolyl-L-leucylglycinamine,” J. Med. Chem., vol. 40, pp. 3594-3600 (1997).
Aicher, et. al., Substitued Tetrahydroprrolo[2,1-b]Oxazol-5(6H)-Ones and Tetrahydropyrrolo[2,1-b]Thiazol-5(6H)-Ones as Hypoglycemic Agents 1, J. Med. Chem. (1998) vol. 41, pp. 4556-4566.
Asakawa, A., et al., Cocaine-Amphetamine-Regulated Transcript Influences Energy Metabolism, Anxiety and Gastric Emptying in Mice, Hormone and Metabolic Research, 2001, vol. 33(9), pp 554-558.
Lee Daniel W et al., Leptin agonists as a potential approach to the treatment of obestiy, Drugs of the Future, 2001, vol. 26(9), pp 873-881.
Okada Hiroshi et al., Synthesis and Antitumor Activities of Prodrugs of Benzoylphenytureas, Chem. Pharm. Bull., 1994, vol. 42(1), pp 57-61.
Salvador Javier et al., Perspectives in the therapeutic use of leptin, Expert Opinion on Pharmacotherapy 2001, 2(10), 1615-1622.
Tyle, Praveen, Iontophoretic Devices for Drug Delivery, Pharmaceutical Research, vol. 3, No. 6, 1986 pp. 318-326.
Zunft, H. et al., Carob Pulp Preparation for Treatment of Hypercholesterolemia, Advances in Therapy, 2001, vol. 18(5), pp 230-236.

Affiliated with

Also associated with

Rating

Bicyclic cyanoheterocycles, process for their preparation... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bicyclic cyanoheterocycles, process for their preparation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic cyanoheterocycles, process for their preparation... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3545590